FDA Recall Alert: Which Cough Drops Are Affected in 2026?
The FDA has issued a Class II recall for specific cough drops due to concerns about product quality. The recall includes several brands and flavors, potentially affecting those who have purchased these products.
The recall was initiated by Xiamen Kang Zhongyuan Biotechnology Co., Ltd. on March 20, 2026, following an inspection of their manufacturing facility in China. The FDA classified it as a Class II recall based on findings that may impact the product's quality, but specifics were not detailed.
Cough Drops Involved in the Recall
The recalled products include Menthol Cough Suppressant bags across various brands and flavors. Details for some of the recalled items are:
Exchange Select, Honey Lemon Flavor, 30-count; Lot: 20241030, Exp: 10/30/2026
Caring Mill, Cherry Flavor, 90-count; Lot: 20241030, Exp: 10/30/2026
MGC Health, Sugar Free Honey Lemon, 25-count; Lots: 20240524 (05/24/2026), 20240720 (07/20/2026)
QC Quality Choice, Black Cherry Flavor, 25-count; Lot: 20240720, Exp: 07/20/2026
Reason for the Recall
The recall resulted from an FDA inspection conducted on August 15, 2025. Observations from this review suggested potential issues with product quality. While the exact nature of these quality concerns was not specified by the FDA, they prompted the classification as a Class II recall.
This classification indicates that exposure to the affected product could lead to temporary or medically reversible adverse health consequences.
